Nasal immunoglobulin for long covid with immune problems
Part of Infections, Lungs & breathing clinical trials.
This study tests whether giving a nasal spray of immunoglobulin (antibodies) helps people with long covid who also have a weakened immune system. It may improve symptoms like fatigue or brain fog.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had covid symptoms lasting at least 12 weeks (long covid).
- You have a diagnosed immune deficiency, such as low antibody levels or high inflammation.
- You do not have an active infection right now.
- You are not taking immunosuppressive drugs (like steroids) and haven't in the last 3 months.
- You do not have a neurological disorder like multiple sclerosis or Parkinson's disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether immune-modulating treatments can help people with long covid, especially those with ongoing heart, cough, or fatigue symptoms. It aims to see if calming the immune system reduces symptoms and improves daily life.
This trial tests a natural compound to help reduce long-term inflammation in people who still have symptoms after a COVID-19 infection. If you're struggling with ongoing symptoms like fatigue or brain fog after COVID-19, this might be worth exploring.
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
This trial tests whether an infusion made from human umbilical cord blood can help people with long COVID (also called post-COVID condition) feel better. It may reduce symptoms by supporting the immune system, though more research is needed.
This trial offers an experimental treatment using umbilical cord blood cells to help people with chronic fatigue from long COVID. The goal is to see if this infusion can reduce fatigue and improve quality of life.
This trial tests if filtering certain antibodies from the blood can help people with long COVID who experience post-exertional malaise (PEM) and reduced function. It aims to see if this treatment reduces symptoms and improves daily life.
Hear when a new Post Acute Sequelae of SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.